Dr. Marcus Bosenberg on Mouse and Other Models for Immunotherapy

Video

In Partnership With:

Marcus Bosenberg, MD, PhD, associate professor of dermatology and pathology, Yale University, discusses mouse models for testing immunotherapies.

Marcus Bosenberg, MD, PhD, associate professor of dermatology and pathology, Yale University, discusses mouse models for testing immunotherapies.

There are two main types of models, says Bosenberg. In one type, the mouse has an intact immune system and tumors can be grafted in. In this case, the mouse serves as a human equivalent, even though there's no human tissue involved. Some people have criticized this method because of the lack of human tissue, says Bosenberg.

A humanized mouse model can also be created by putting a human immune system in a mouse and then, using human cancer cells, observe how that immune reaction works.

This is very difficult to do, says Bosenberg. However, a lot of progress has been made in this area.

There are also other non-mouse models that are used in immunotherapy. For example, dogs have a very high rate of melanoma, so potentially dogs could also be used as a spontaneous model for immunotherapy development.

This however, would take a significant amount of infrastructure to make work, says Bosenberg. While this has not occurred yet, it is a possibility, he says

Bosenberg will speak on the topic of future directions in cancer immune models at the Society for Immunotherapy of Cancer (SITC) 31st Annual Meeting & Associated Programs November 9-13, 2016.

Related Videos
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center